Scarica l'app Stockscreener
1.1096
0.04%
-0.0004
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.11
Aprire:
$1.11
Volume 24 ore:
11,014
Relative Volume:
0.45
Capitalizzazione di mercato:
$12.84M
Reddito:
$996.00K
Utile/perdita netta:
$-6.09M
Rapporto P/E:
-2.0936
EPS:
-0.53
Flusso di cassa netto:
$-9.76M
1 W Prestazione:
+2.74%
1M Prestazione:
+0.42%
6M Prestazione:
+44.18%
1 anno Prestazione:
-38.01%
Intervallo 1D:
$1.09
$1.126
Intervallo di 1 settimana:
$1.06
$1.24
Portata 52W:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Nome
Therapeuticsmd Inc
Settore
Telefono
561-961-1900
Indirizzo
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Confronta TXMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.1096 | 12.73M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-07 | Downgrade | Jefferies | Hold → Underperform |
| 2020-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Iniziato | Guggenheim | Buy |
| 2019-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-30 | Ripresa | Noble Capital Markets | Outperform |
| 2018-06-15 | Iniziato | JP Morgan | Overweight |
| 2017-09-08 | Iniziato | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Ripresa | Jefferies | Buy |
| 2016-11-22 | Iniziato | Oppenheimer | Outperform |
| 2016-11-07 | Ripresa | Guggenheim | Buy |
| 2016-04-04 | Iniziato | Goldman | Buy |
| 2015-12-08 | Reiterato | Jefferies | Buy |
| 2015-12-08 | Reiterato | Stifel | Buy |
| 2015-09-21 | Reiterato | Jefferies | Buy |
| 2015-06-09 | Iniziato | Guggenheim | Buy |
| 2014-07-08 | Iniziato | FBR Capital | Outperform |
| 2014-04-17 | Reiterato | Noble Financial | Buy |
| 2014-01-28 | Reiterato | Noble Financial | Buy |
Mostra tutto
Therapeuticsmd Inc Borsa (TXMD) Ultime notizie
Live market analysis of TherapeuticsMD Inc.Insider Selling & Free Expert Verified Stock Movement Alerts - Newser
Is TherapeuticsMD Inc. stock poised for growthTrade Analysis Summary & Community Verified Swing Trade Signals - Newser
TherapeuticsMD Inc. stock momentum explainedQuarterly Profit Summary & Long-Term Safe Investment Ideas - Newser
Momentum divergence signals in TherapeuticsMD Inc. chartChart Signals & High Conviction Buy Zone Picks - Newser
What machine learning models say about TherapeuticsMD Inc.Market Risk Summary & Daily Entry Point Trade Alerts - Newser
Will TherapeuticsMD Inc. stock recover after recent dropQuarterly Risk Review & AI Optimized Trading Strategy Guides - Newser
TherapeuticsMD Inc. stock trend forecast2025 Earnings Surprises & Long-Term Investment Growth Plans - Newser
What indicators show strength in TherapeuticsMD Inc.Buy Signal & Community Verified Trade Alerts - Newser
Relative strength of TherapeuticsMD Inc. in sector analysisJuly 2025 Update & Short-Term Swing Trade Alerts - Newser
Will breakout in TherapeuticsMD Inc. lead to full recoveryRisk Management & Stepwise Trade Signal Implementation - Newser
Published on: 2025-09-11 23:46:09 - Newser
What technical models suggest about TherapeuticsMD Inc.’s comebackMarket Growth Summary & Expert Curated Trade Ideas - Newser
How to escape a deep drawdown in TherapeuticsMD Inc.Trend Reversal & Free Safe Capital Growth Stock Tips - Newser
Visual analytics tools that track TherapeuticsMD Inc. performance2025 Top Decliners & AI Based Buy and Sell Signals - Newser
Using portfolio simulators with TherapeuticsMD Inc. includedEarnings Recap Report & AI Driven Stock Reports - Newser
Risk vs reward if holding onto TherapeuticsMD Inc.July 2025 Fed Impact & Consistent Profit Focused Trading Strategies - Newser
Applying big data sentiment scoring on TherapeuticsMD Inc.Quarterly Risk Review & Weekly Market Pulse Alerts - Newser
Applying sector rotation models to TherapeuticsMD Inc.July 2025 Patterns & Risk Controlled Swing Alerts - Newser
Is a relief rally coming for TherapeuticsMD Inc. holdersEarnings Recap Summary & High Conviction Buy Zone Alerts - Newser
Advanced analytics toolkit walkthrough for TherapeuticsMD Inc.Stop Loss & Daily Entry Point Trade Alerts - Newser
Automated trading signals detected on TherapeuticsMD Inc.Market Risk Summary & Expert Verified Movement Alerts - Newser
TherapeuticsMD Inc. stock trend outlook and recovery pathJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - Newser
Tools to monitor TherapeuticsMD Inc. recovery probabilityJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - Newser
Can volume confirm reversal in TherapeuticsMD Inc.July 2025 Macro Moves & Capital Protection Trading Alerts - Newser
How to track smart money flows in TherapeuticsMD Inc.Stop Loss & Verified Stock Trade Ideas - Newser
What to do if you’re stuck in TherapeuticsMD Inc.July 2025 Pullbacks & Capital Efficient Trade Techniques - Newser
Has TherapeuticsMD Inc. found a price floorJuly 2025 Summary & Daily Stock Trend Reports - Newser
Published on: 2025-09-09 04:08:51 - Newser
Therapeuticsmd Inc Azioni (TXMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Therapeuticsmd Inc Azioni (TXMD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
2.67%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):